Low-density lipoprotein-cholesterol lowering in individuals at intermediate cardiovascular risk: Percent reduction or target level?
Fernando Henpin Yue CesenaAntonio Gabriele LaurinaviciusViviane A ValenteRaquel D ConceiçãoRaul D SantosMarcio S BittencourtPublished in: Clinical cardiology (2018)
In an intermediate-risk population, cardiovascular benefit from LDL-c lowering may be optimized by tailoring the treatment according to the baseline LDL-c or by setting a dual-target strategy (fixed dose statin plus achievement of target LDL-c concentration).